Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

171
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
171
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

134
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
134

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Extrapleural Pneumonectomy for Treatment of Pulmonary Adenoid Cystic Carcinoma.

Annals of thoracic surgery short reports·2025
Same author

Multidisciplinary management of a complex case of postesophagectomy tracheoesophageal fistula.

JTCVS techniques·2025
Same author

Surgical approaches for thymectomy: a narrative review.

Mediastinum (Hong Kong, China)·2025
Same author

Gastropericardial Fistula After Collis Gastroplasty and Nissen Fundoplication.

Annals of thoracic surgery short reports·2025
Same author

Esophageal perforation after anterior cervical spine surgery.

JTCVS techniques·2024
Same author

A nationwide analysis of disparities in guideline-concordant care in American Indians and Alaska Natives with stage I non-small cell lung cancer.

Journal of thoracic disease·2023

相关实验视频

Updated: May 23, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.2K

在结肠癌中辅助化疗:简单更好...更少是更多.

Prasad Narayanan1, Shyam Aggarwal2, Manish Singhal3

  • 1Department of Medical Oncology, Cytecare Hospital, Bengaluru, Karnataka, India.

South Asian journal of cancer
|March 10, 2025
PubMed
概括

辅助治疗改善了结直肠癌 (CRC) 患者的治疗结果. 像CAPOX和SOX这样的更短的疗程提供了标准FOLFOX的替代方案,个性化的选择提高了治疗效率.

关键词:
在MRD中,我们可以使用MRD.ctDNActDNA是什么意思药物代谢 药物代谢老年患者的患者.总体存活率 总体存活率毒性的毒性 毒性的毒性

更多相关视频

Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS
12:37

Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS

Published on: September 11, 2012

46.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

199

相关实验视频

Last Updated: May 23, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.2K
Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS
12:37

Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS

Published on: September 11, 2012

46.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

199

科学领域:

  • 在瘤学瘤学.
  • 医学瘤学 医学瘤学
  • 胃肠病学 胃肠病学

背景情况:

  • 辅助疗法显著有利于结直肠癌 (CRC) 的患者.
  • 目前的标准治疗包括6个月的FOLFOX治疗,但如CAPOX和SOX等更短的治疗方案正在出现.
  • 诸如SCOT,TOSCA,Alliance/SWOG80702,IDEA,ACHIEVE和HORG等临床试验正在评估这些治疗方法.

研究的目的:

  • 审查目前对结直肠癌的辅助疗法选择.
  • 讨论患者偏好和新生物标志物在治疗选择中的作用.
  • 为了突出对老年CRC患者的考虑.

主要方法:

  • 关键临床试验的综述,比较CRC的辅助化疗方案.
  • 分析影响治疗决策的因素,包括患者偏好和分子标记.
  • 考虑在治疗CRC的老年患者方面面临的具体挑战.

主要成果:

  • 较短的辅助化疗方案 (CAPOX,SOX) 是标准FOLFOX的可行的替代方案.
  • 使用分子生物标志物和循环瘤DNA (ctDNA) 优化患者选择,以进行最小残留疾病 (MRD) 监测.
  • 老年患者由于并发病,多药和移动性问题需要特别注意.

结论:

  • 优化结直肠癌的辅助疗法包括平衡疗效与患者特定因素.
  • 个性化治疗选择,包括生物标志物和患者偏好,对于改善治疗结果至关重要.
  • 针对性管理策略对于接受CRC治疗的老年人群至关重要.